CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Fair Value Disclosure
| December 27, 2025 | |||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
| Current assets measured at fair value: | (in thousands) | ||||||||||||||||||||||
| Other assets: | |||||||||||||||||||||||
| Life insurance policies | — | 58,427 | — | 58,427 | |||||||||||||||||||
| Total assets measured at fair value | $ | — | $ | 58,427 | $ | — | $ | 58,427 | |||||||||||||||
| Accrued liabilities measured at fair value: | |||||||||||||||||||||||
| Contingent consideration | $ | — | $ | — | $ | 30,000 | $ | 30,000 | |||||||||||||||
| Total liabilities measured at fair value | $ | — | $ | — | $ | 30,000 | $ | 30,000 | |||||||||||||||
| December 28, 2024 | |||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
| Current assets measured at fair value: | (in thousands) | ||||||||||||||||||||||
| Cash equivalents | $ | — | $ | 30 | $ | — | $ | 30 | |||||||||||||||
| Other assets: | |||||||||||||||||||||||
| Life insurance policies | — | 48,152 | — | 48,152 | |||||||||||||||||||
| Total assets measured at fair value | $ | — | $ | 48,182 | $ | — | $ | 48,182 | |||||||||||||||
| Accrued liabilities measured at fair value: | |||||||||||||||||||||||
| Contingent consideration | $ | — | $ | — | $ | 25,000 | $ | 25,000 | |||||||||||||||
| Other long-term liabilities measured at fair value: | |||||||||||||||||||||||
| Contingent consideration | — | — | 24,311 | 24,311 | |||||||||||||||||||
| Total liabilities measured at fair value | $ | — | $ | — | $ | 49,311 | $ | 49,311 | |||||||||||||||
| Fiscal Year | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (in thousands) | |||||||||||||||||
| Beginning balance | $ | 49,311 | $ | 33,265 | $ | 13,431 | |||||||||||
| Additions | — | — | 33,265 | ||||||||||||||
| Payments | (25,000) | — | (15,130) | ||||||||||||||
| Total gains or losses (realized/unrealized): | |||||||||||||||||
| Adjustment of previously recorded contingent liability | 5,689 | 16,046 | 1,810 | ||||||||||||||
| Foreign currency translation | — | — | (111) | ||||||||||||||
| Ending balance | $ | 30,000 | $ | 49,311 | $ | 33,265 | |||||||||||
| December 27, 2025 | December 28, 2024 | ||||||||||||||||||||||
| Book Value | Fair Value | Book Value | Fair Value | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
4.25% Senior Notes due 2028 | $ | 500,000 | $ | 493,800 | $ | 500,000 | $ | 473,750 | |||||||||||||||
3.75% Senior Notes due 2029 | 500,000 | 483,550 | 500,000 | 456,250 | |||||||||||||||||||
4.00% Senior Notes due 2031 | 500,000 | 474,050 | 500,000 | 441,250 | |||||||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 18, 2026 | Showing above |
| 2024 | Feb 19, 2025 | |
| 2023 | Feb 14, 2024 | |
| 2022 | Feb 22, 2023 | |
| 2021 | Feb 16, 2022 | |
| 2020 | Feb 17, 2021 | |
| 2019 | Feb 11, 2020 | |
| 2018 | Feb 13, 2019 | |
| 2017 | Feb 13, 2018 | |
| 2016 | Feb 14, 2017 | |
| 2015 | Feb 12, 2016 | |
About Fair Value Disclosures
Fair value disclosures classify all assets and liabilities measured at fair value into a three-level hierarchy: Level 1 (quoted market prices), Level 2 (observable inputs like yield curves), and Level 3 (unobservable inputs requiring management estimates). The proportion of Level 3 assets directly reflects how much of the balance sheet depends on internal models rather than market evidence.
Key signals: a growing Level 3 balance relative to total fair-value assets increases valuation uncertainty and earnings volatility risk. Watch for transfers between levels — assets moving from Level 2 to Level 3 often signal deteriorating market liquidity. Unrealized gains and losses on Level 3 positions flow through earnings or other comprehensive income, so large swings deserve scrutiny. For financial institutions, examine the sensitivity disclosures that show how Level 3 valuations change under alternative assumptions. Compare the fair value of debt against its carrying amount to gauge hidden leverage.